Physician profile
Steven Wang
NPI 1881807659
$2,413.66
in general payments reported to CMS, 2019-2025
11 companies · $1,796 in 2025
The $1,796 reported for 2025 was more than what 90% of Anatomic Pathology & Clinical Pathology providers received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $300 · 2022: $39.77 · 2023: $179 · 2024: $99.13 · 2025: $1,796.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,083 · Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,082.66 |
| Food and Beverage | $990.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,784.69 | 2023-2025 | Inspire |
| Cochlear Americas | $183.66 | 2024-2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Novartis Pharmaceuticals Corporation | $125.01 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $87.85 | 2021 | |
| Janssen Pharmaceuticals, INC | $73.56 | 2022-2023 | Xarelto |
| Abbott Laboratories | $69.28 | 2021-2022 | |
| Esperion Therapeutics, INC. | $22.76 | 2025 | Nexletol |
| Alnylam Pharmaceuticals INC. | $20.32 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.10 | 2025 | Lifevest |
| Novo Nordisk INC | $16.17 | 2021 | |
| Roche Diagnostics Corporation | $13.26 | 2023 | Cintec Plus Cytology |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.